Clinical Trial

The Role of Probiotics in the Treatment of Endometriosis (ProMetrioS): a Randomised Double-blinded Placebo-controlled Cross-over Trial

Study acronym: ProMetrioS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2025 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
ProMetrioS is a randomised blinded placebo-controlled cross-over trial investigating the effect of specific multistrain probiotics in patients with endometriosis. The aim of this clinical trial is to determine whether probiotic treatment can significantly modulate gut microbiome composition and functionality in endometriosis patients, specifically parameters associated with the estrobolome.
Trial Details
NCT Number NCT06929364
Lead Sponsor The Gut Microbiome Center (Centar za crijevni mikrobiom)
Collaborators: Clinical Hospital Centre Zagreb
Conditions Endometriosis, Probiotics
Enrollment 40 participants
Start Date 2024-11-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-16